WHITE PLAINS, N.Y., Oct. 17, 2013 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) is committed to bringing the most current information about blood cancers to all patients and is pleased to announce a unique educational opportunity for Spanish-speaking patients with pediatric acute lymphoblastic leukemia (ALL) and their caregivers. On Wednesday, October 23 from 1:00 to 2:30 PM Eastern Time, Susan R. Rheingold, M.D. and Cara L. Simon, Ph.D., APRN, CPNP, from The Children's Hospital of Philadelphia, will speak on LLS's free, live telephone/web education program titled Pediatric ALL – Update on Treatment and Follow-Up Care. This program will be presented in English and simultaneously interpreted into Spanish.
Acute lymphoblastic leukemia (ALL) is a complex heterogeneous disease and there have been significant advances in the treatment of pediatric patients. ALL represents nearly one-third of all pediatric cancers and is the most common malignancy diagnosed in children. It is critical for physicians who treat pediatric ALL patients to maintain an up-to-date understanding of the factors that affect the management of this challenging disease.
The telephone/web program on October 23 will provide Spanish-speaking patients and caregivers the opportunity to learn about the latest advances in pediatric ALL treatment and quality of life issues from two experts in the field. Drs. Rheingold and Simon will provide information on current treatment options, clinical trials, side effects management, as well as the importance of follow-up care. This program, offered by LLS in collaboration with Abrale and Alianza Latina, is supported by a grant from Jazz Pharmaceuticals and offers continuing education credit for nurses and social workers.
To register for the October 23, 2013 program: Pediatric ALL – Update on Treatment and Follow-Up Care in Spanish, please visit www.LLS.org/ALLsp.
To register for Pediatric ALL – Update on Treatment and Follow-Up Care in English, please visit www.LLS.org/professionaled.
For information on other LLS programs, please visit www.LLS.org or contact an Information Specialist at (800) 955-4572.
About The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society ® (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, multiple myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world, provides free information and support services, and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care.
Founded in 1949 and headquartered in White Plains, NY, LLS has chapters throughout the United States and Canada. To learn more, visit www.LLS.org. Patients should contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET.
Contact: Andrea Greif
SOURCE The Leukemia & Lymphoma Society